← Leaderboards
Peter W. Stacpoole
University Of Florida
$22,176,893
Attributed
$26,221,090
Total exposure
40
Grants
27
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.2M · FY2005–24$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$20,891,942 · 38
FDA$5,542,892 · 3
By mechanism
R01$14,464,626 · 6
R42$4,692,027 · 1
UL1$4,392,483 · 5
M01$1,807,109 · 25
P42$526,576 · 1
P20$427,488 · 2
Top collaborators
- Margaret O James10 shared
- Chetan Bettegowda4 shared
- Stuart A Grossman4 shared
- John L Thompson4 shared
Most similar at University Of Florida
Same institution · by research overlap
- Margaret O James$2,557,334
- Angela S Lindner$526,576
- Maureen Keller-Wood$9,398,553
Others in their field
Top investigators on “Dichloroacetate”
- David Heimbrook · Leidos Biomedical Research, Inc.$36,423,772
- Amato J. Giaccia · Stanford University$6,295,499
- Larry Arthur$5,909,000
- David T Chuang · University Of Texas Sw Med Ctr/Dallas$2,943,584
- Maureen Keller-Wood · University Of Florida$2,773,846
- Andrew Mizisin · Winsantor, Inc.$1,997,420
Research focus
DichloroacetateClinical ResearchLactic AcidosisDoseTyrosineChronicHuman SubjectMetabolismKineticsHaplotypesEnzymesChildMetabolic BiotransformationGlyoxylateCatabolismHepaticAdultToxic EffectAdverse EffectsIn VivoExhibitsPropertyLiverFunding
Grant awards (91)
Phase IIA Trial of Dichloroacetate for Glioblastoma Multiforme, IND137007, 09172019$669,027
R01 · FY2024 · FD · contact PI
Phase IIA Trial of Dichloroacetate for Glioblastoma Multiforme, IND137007, 09172019$660,372
R01 · FY2023 · FD · contact PI
Personalized dosing of dichloroacetate for the treatment of rare and common diseases$985,330
R42 · FY2022 · HD · contact PI
Phase IIA Trial of Dichloroacetate for Glioblastoma Multiforme, IND137007, 09172019$659,650
R01 · FY2022 · FD · contact PI
Phase 3 Trial of DCA in PDC Deficiency IND 028,625 (02/04/2015)$496,401
R01 · FY2022 · FD · contact PI
Personalized dosing of dichloroacetate for the treatment of rare and common diseases$992,757
R42 · FY2021 · HD · contact PI
Phase IIA Trial of Dichloroacetate for Glioblastoma Multiforme, IND137007, 09172019$541,558
R01 · FY2021 · FD · contact PI
Phase 3 Trial of DCA in PDC Deficiency IND 028,625 (02/04/2015)$492,395
R01 · FY2021 · FD · contact PI
Personalized dosing of dichloroacetate for the treatment of rare and common diseases$1,000,000
R42 · FY2020 · HD · contact PI
Developmental Pharmacology of Mitochondrial and Cytosolic GSTZ1$340,075
R01 · FY2019 · GM
Personalized dosing of dichloroacetate for the treatment of rare and common diseases$695,065
R42 · FY2018 · HD · contact PI
Phase 3 Trial of DCA in PDC Deficiency IND 028,625 (02/04/2015)$494,425
R01 · FY2018 · FD · contact PI
Developmental Pharmacology of Mitochondrial and Cytosolic GSTZ1$340,075
R01 · FY2018 · GM
Personalized dosing of dichloroacetate for the treatment of rare and common diseases$793,897
R42 · FY2017 · HD · contact PI
Developmental Pharmacology of Mitochondrial and Cytosolic GSTZ1$388,915
R01 · FY2017 · GM
Diversity Supplement to 2RO1 GM 099871$48,840
R01 · FY2017 · GM
Phase 3 Trial of DCA in PDC Deficiency IND 028,625 (02/04/2015)$491,601
R01 · FY2016 · FD · contact PI
Developmental Pharmacology of Mitochondrial and Cytosolic GSTZ1$340,075
R01 · FY2016 · GM
Personalized dosing of dichloroacetate for the treatment of rare and common diseases$224,978
R42 · FY2016 · HD · contact PI
Developmental Pharmacology of cytosolic and mitochondrial GSTZ1-1/MAAI$321,530
R01 · FY2015 · GM
Developmental Pharmacology of cytosolic and mitochondrial GSTZ1-1/MAAI$324,954
R01 · FY2014 · GM
Developmental Pharmacology of cytosolic and mitochondrial GSTZ1-1/MAAI$312,950
R01 · FY2013 · GM
Developmental Pharmacology of cytosolic and mitochondrial GSTZ1-1/MAAI$28,486
R01 · FY2013 · GM
Developmental Pharmacology of cytosolic and mitochondrial GSTZ1-1/MAAI$293,530
R01 · FY2012 · GM
PHASE 3 TRIAL OF COENZYME IN MITOCHONDRIAL DISEASE$75,000
R01 · FY2011 · FD · contact PI
Pharmacotoxicology of Trichloroethylene Metabolites$325,543
R01 · FY2010 · ES · contact PI
PHASE 3 TRIAL OF COENZYME IN MITOCHONDRIAL DISEASE$322,322
R01 · FY2010 · FD · contact PI
Planning Grant for Phase 3 Trial of Dichloroacetate in PDH Deficiency$124,525
R34 · FY2010 · HD · contact PI
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH$2,133,296
UL1 · FY2009 · RR · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS$1,279,970
UL1 · FY2009 · RR · contact PI
UF CLINICAL AND TRANSLATIONAL SCIENCE AWARD$725,331
UL1 · FY2009 · RR · contact PI
Pharmacotoxicology of Trichloroethylene Metabolites$378,067
R01 · FY2009 · ES · contact PI
Pharmacotoxicology of Trichloroethylene Metabolites$328,831
R01 · FY2009 · ES · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$126,943
UL1 · FY2009 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$126,943
UL1 · FY2009 · RR · contact PI
PHARMACOTOXICOLOGY OF TRICHLOROETHYLENE METABOLITES$55,606
M01 · FY2009 · RR · contact PI
Dichloroacetate Kinetics, Metabolism and Toxicology$44,732
R01 · FY2009 · ES · contact PI
CLINICAL TRIAL: DICHLOROACETATE TREATMENT OF CONGENITAL LACTIC ACIDOSIS$18,198
M01 · FY2009 · RR · contact PI
Pharmacotoxicology of Trichloroethylene Metabolites$15,341
R01 · FY2009 · ES · contact PI
CLINICAL TRIAL: THE EFFECT OF DICHLOROACETATE ON AEROBIC FUNCTION AND WORK CAPAC$3,033
M01 · FY2009 · RR · contact PI
PILOT STUDY OF DCA EFFECTS ON HUMAN TYROSINE METABOLISM$2,224
M01 · FY2009 · RR · contact PI
DICHLOROACETATE TREATMENT OF CLA PRESENTING IN INFANCY$1,820
M01 · FY2009 · RR · contact PI
Dichloroacetate Kinetics, Metabolism and Toxicology$507,183
R01 · FY2008 · ES · contact PI
Pharmacotoxicology of Trichloroethylene Metabolites$328,831
R01 · FY2008 · ES · contact PI
PHARMACOTOXICOLOGY OF TRICHLOROETHYLENE METABOLITES$46,067
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: DICHLOROACETATE TREATMENT OF CONGENITAL LACTIC ACIDOSIS$44,442
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: THE EFFECT OF DICHLOROACETATE ON AEROBIC FUNCTION AND WORK CAPAC$13,549
M01 · FY2008 · RR · contact PI
Dichloroacetate Kinetics, Metabolism and Toxicology$565,430
R01 · FY2007 · ES · contact PI
PHASE 3 TRIAL OF COENZYME IN MITOCHONDRIAL DISEASE$344,098
R01 · FY2007 · FD · contact PI
Pharmacotoxicology of Trichloroethylene Metabolites$335,542
R01 · FY2007 · ES · contact PI
DICHLOROACETATE TREATMENT OF CONGENITAL LACTIC ACIDOSIS$57,353
M01 · FY2007 · RR · contact PI
THE EFFECT OF DICHLOROACETATE ON AEROBIC FUNCTION AND WORK CAPACITY IN$23,585
M01 · FY2007 · RR · contact PI
PHARMACOTOXICOLOGY OF TRICHLOROETHYLENE METABOLITES$16,080
M01 · FY2007 · RR · contact PI
Dichloroacetate Kinetics, Metabolism and Toxicology$570,056
R01 · FY2006 · ES · contact PI
Pharmacotoxicology of Trichloroethylene Metabolites$345,563
R01 · FY2006 · ES · contact PI
PHASE 3 TRIAL OF COENZYME IN MITOCHONDRIAL DISEASE$296,043
R01 · FY2006 · FD · contact PI
Institutional CTSA Planning Grant$213,744
P20 · FY2006 · RR · contact PI
INSTITUTIONAL CTSA PLANNING GRANT$213,744
P20 · FY2006 · RR · contact PI
DICHLOROACETATE TREATMENT OF CONGENITAL LACTIC ACIDOSIS$83,182
M01 · FY2006 · RR · contact PI
THE EFFECT OF DICHLOROACETATE ON AEROBIC FUNCTION AND WORK CAPACITY IN$35,650
M01 · FY2006 · RR · contact PI
PHARMACOTOXICOLOGY OF TRICHLOROETHYLENE METABOLITES$11,883
M01 · FY2006 · RR · contact PI
Dichloroacetate Kinetics, Metabolism and Toxicology$571,449
R01 · FY2005 · ES
DICHLOROACETATE TREATMENT OF CONGENITAL LACTIC ACIDOSIS*$94,513
M01 · FY2005 · RR
THE EFFECT OF DICHLOROACETATE ON AEROBIC FUNCTION AND WORK CAPACITY IN$36,983
M01 · FY2005 · RR
PREVENTION OF DICHLOROACETATE TOXICITY$14,382
M01 · FY2005 · RR
PHARMACOTOXICOLOGY OF TRICHLOROETHYLENE METABOLITES$6,164
M01 · FY2005 · RR
Dichloroacetate Kinetics, Metabolism and Toxicology$594,087
R01 · FY2004 · ES
Dichloroacetate Kinetics and Metabolism$179,263
M01 · FY2004 · RR
Dichloroacetate Treatment of Congenital Lactic Acidosis*$120,581
M01 · FY2004 · RR
Prevention of Dichloroacetate Toxicity$94,053
M01 · FY2004 · RR
DICHLOROACETATE KINETICS, METABOLISM AND TOXICOLOGY$368,596
R01 · FY2002 · ES
DICHLOROACETATE KINETICS, METABOLISM AND TOXICOLOGY$197,750
R01 · FY2002 · ES
Pharmacology of trichloroethylene metabolites$131,644
P42 · FY2002 · ES
Pharmacology of trichloroethylene metabolites$131,644
P42 · FY2002 · ES
DICHLOROACETATE KINETICS, METABOLISM AND TOXICOLOGY$357,863
R01 · FY2001 · ES
DICHLOROACETATE TREATMENT OF CONGENITAL LACTIC ACIDOSIS$207,281
M01 · FY2001 · RR
PATHOBIOLOGY &TREATMENT OF MALARIA IN AFRICA$207,281
M01 · FY2001 · RR
Pharmacology of trichloroethylene metabolites$131,644
P42 · FY2001 · ES
DICHLOROACETATE TREATMENT OF CONGENITAL LACTIC ACIDOSIS$55,741
M01 · FY2001 · RR
PATHOBIOLOGY &TREATMENT OF MALARIA IN AFRICA$55,741
M01 · FY2001 · RR
DICHLOROACETATE KINETICS, METABOLISM AND TOXICOLOGY$347,440
R01 · FY2000 · ES
TREATMENT OF CONGENITAL LACTIC ACIDOSIS WITH SODIUM DICHLOROACETATE$207,281
M01 · FY2000 · RR
Pharmacology of trichloroethylene metabolites$131,644
P42 · FY2000 · ES
DICHLOROACETATE TREATMENT OF CONGENITAL LACTIC ACIDOSIS$38,391
M01 · FY2000 · RR
PATHOBIOLOGY &TREATMENT OF MALARIA IN AFRICA$38,391
M01 · FY2000 · RR
TREATMENT OF CONGENITAL LACTIC ACIDOSIS WITH SODIUM DICHLOROACETATE$38,391
M01 · FY2000 · RR
DICHLOROACETATE KINETICS AND METABOLISM$0
M01 · FY2000 · RR
DICHLOROACETATE TREATMENT OF CONGENITAL LACTIC ACIDOSIS$0
M01 · FY2000 · RR
PHYSIOLOGY/COGNITION--RITALIN IN SLEEP DEPRIVED STUDENT$0
M01 · FY2000 · RR
PHYSIOLOGY/COGNITION--RITALIN IN SLEEP DEPRIVED STUDENT$0
M01 · FY2000 · RR
DICHLOROACETATE KINETICS AND METABOLISM$0
M01 · FY2000 · RR